240 related articles for article (PubMed ID: 25589331)
1. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
Singh K; Prasad KN; Mishra P; Singh SK; Kharwar NK; Prasad N; Gupta A; Srivastava JK
Nephrology (Carlton); 2015 Jun; 20(6):387-91. PubMed ID: 25589331
[TBL] [Abstract][Full Text] [Related]
2. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
3. Prediction of susceptible biomarkers for end stage renal disease among North Indians.
Prakash S; Sarangi AN; Tripathi G; Sharma RK; Agrawal S
Nephrology (Carlton); 2016 Jul; 21(7):592-600. PubMed ID: 26421528
[TBL] [Abstract][Full Text] [Related]
4. Association of IL-6, IL-10, and TNF-α gene polymorphism with malnutrition inflammation syndrome and survival among end stage renal disease patients.
Sharma R; Agrawal S; Saxena A; Sharma RK
J Interferon Cytokine Res; 2013 Jul; 33(7):384-91. PubMed ID: 23777202
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.
Singh K; Prasad KN; Mishra P; Khatoon J; Prasad N; Gupta A; Srivastava JK
Int Urol Nephrol; 2015 Dec; 47(12):2031-7. PubMed ID: 26490558
[TBL] [Abstract][Full Text] [Related]
6. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
7. Association between interleukin-10 gene polymorphism -592 (A/C) and peritoneal transport in patients undergoing peritoneal dialysis.
Lee YT; Tsai YC; Yang YK; Hsu KT; Liao SC; Wu CH; Cheng BC; Chen JB; Lee CH; Lee CT
Nephrology (Carlton); 2011 Sep; 16(7):663-71. PubMed ID: 21777343
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
[TBL] [Abstract][Full Text] [Related]
9. Association of TNF-α (-238 and -308) promoter polymorphisms with susceptibility of oral squamous cell carcinoma in North Indian population.
Singh PK; Bogra J; Chandra G; Ahmad MK; Gupta R; Kumar V; Jain A; Ali Mahdi A
Cancer Biomark; 2015; 15(2):125-31. PubMed ID: 25519014
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α and interleukin-1β gene polymorphisms and risk of brain abscess in North Indian population.
Mishra P; Prasad KN; Singh K; Bajpai A; Sahu RN; Ojha BK
Cytokine; 2015 Sep; 75(1):159-64. PubMed ID: 26187330
[TBL] [Abstract][Full Text] [Related]
11. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease.
Buraczynska M; Mierzicki P; Buraczynska K; Dragan M; Ksiazek A
Mol Diagn Ther; 2007; 11(4):257-63. PubMed ID: 17705580
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis.
Buraczynska K; Koziol-Montewka M; Majdan M; Ksiazek A
Mol Diagn; 2003; 7(3-4):175-80. PubMed ID: 15068388
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α -308 G/A and interleukin 10 -1082 A/G gene polymorphisms in patients with acne vulgaris.
Al-Shobaili HA; Salem TA; Alzolibani AA; Robaee AA; Settin AA
J Dermatol Sci; 2012 Oct; 68(1):52-5. PubMed ID: 22835835
[TBL] [Abstract][Full Text] [Related]
17. Association of the -1031T>C polymorphism and soluble TNF-α levels with Acute Coronary Syndrome.
Sandoval-Pinto E; Padilla-Gutiérrez JR; Valdés-Alvarado E; García-González IJ; Valdez-Haro A; Muñoz-Valle JF; Flores-Salinas HE; Brennan-Bourdon LM; Valle Y
Cytokine; 2016 Feb; 78():37-43. PubMed ID: 26618233
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of anti-alphaGalactosyl antibodies predict survival and peritoneal dialysis-related enteric peritonitis rates in patients undergoing renal replacement therapy.
Fontán MP; Máñez R; Rodríguez-Carmona A; Peteiro J; Martínez V; García-Falcón T; Domenech N
Am J Kidney Dis; 2006 Dec; 48(6):972-82. PubMed ID: 17162152
[TBL] [Abstract][Full Text] [Related]
19. Gene polymorphisms of tumor necrosis factor alpha and antioxidant enzymes in bronchial asthma.
Despotovic M; Stoimenov TJ; Stankovic I; Pavlovic D; Sokolovic D; Cvetkovic T; Kocic G; Basic J; Veljkovic A; Djordjevic B
Adv Clin Exp Med; 2015; 24(2):251-6. PubMed ID: 25931357
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of MCP-1 -2518 A>G promoter polymorphism in Turkish chronic renal failure patients requiring long-term hemodialysis.
Bagci B; Bagci G; Candan F; Ozdemir O; Sezgin I
Int Urol Nephrol; 2015 Mar; 47(3):551-6. PubMed ID: 25655256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
